Menu

Image of the Day: Pterosaur Fossils

Paleontologists find fossils from at least seven species of the flying reptiles in Morocco.

Mar 14, 2018
The Scientist Staff, The Scientist Staff

T. regalis ulnaeN.R. LONGRICH ET AL.Pterosaurs—the largest animals ever to take flight—ruled the skies for more than 150 million years before they went extinct at the end of the Cretaceous period, about 65 million years ago. Yesterday (March 13), researchers announced in PLOS Biology that they unearthed multiple pterosaur fossils in North Africa. The discovery includes at least seven species from three families and is the most diverse group of pterosaur fossils found to date.

The collection of assorted species indicates that pterosaur diversity was more abundant at the close of the Cretaceous than paleontologists previously believed, pterosaur expert Elizabeth Martin-Silverstone of the University of Southampton tells Smithsonian.com. While the winged reptiles were “maybe less diverse than they were at their height,” Martin-Silverstone says, they were “doing better than we initially appreciated.”

N.R. Longrich et al., “Late Maastrichtian pterosaurs from North Africa and mass extinction of Pterosauria at the Cretaceous-Paleogene boundary,” PLOS Biology, doi:10.1371/journal.pbio.2001663, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.